Skip to main content
Top

Clinical and Translational Oncology

Issue 7/2010

Content (11 Articles)

News and Views

The art of providing care

Enrique García Jordá

Educational Series

Breast cancer, neoadjuvant chemotherapy and residual disease

Mariana Chávez-MacGregor, Ana María González-Angulo

Educational Series

Tyrosine kinase inhibitors in treating soft tissue sarcomas: sunitinib in non-GIST sarcomas

Blanca Homet Moreno, Elena Garralda Cabanas, Ricardo Hitt

Educational Series

Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review

Ketao Jin, Lisong Teng, Yanping Shen, Kuifeng He, Zhenzhen Xu, Guangliang Li

Educational Series

Advances in the therapy of gastroenteropancreatic-neuroendocrine tumours (GEP-NETs)

Enrique Grande, Juan José Díez, Vanessa Pachón, Alfredo Carrato

Special Article

Controversies on the management of clinical situations with low therapeutic effectiveness in oncology

José Expósito, Juan José Bretón, Carmen Domínguez, Joana Pons

Research Articles

Sentinel lymph node biopsy in selected cases of ductal carcinoma in situ

María Vicenta Collado, Jaime Ruiz-Tovar, Augusto García-Villanueva, Roberto Rojo, Lucía Latorre, María Eugenia Rioja, Fernando González-Palacios

Research Articles

A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01

Joaquim Bellmunt, Pablo Maroto-Rey, José M. Trigo, Joan Carles, Vicente Guillem, José A. López-Martín, Antonio Antón-Torres, Leyrer Urruticoechea

Case Reports

Orbital and myocardial metastases of a primary pulmonary melanotic schwannoma

Robert Díaz Beveridge, Paula Richart Aznar, Cornelio Núñez Lozano, Melitina Chirivella Casanova, Miguel Corbellas Aparicio, Joaquín Montalar Salcedo

Case Reports

Neuroendocrine small cell carcinoma of the uterine cervix

Anna Reig Castillejo, Ismael Membrive Conejo, Palmira Foro Arnalot, Nuria Rodríguez de Dios, Manuel Algara López

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine